Denali Therapeutics Inc.
← Back to DNLI Overview

Denali Therapeutics Inc. (DNLI)

Solvency & Capital Structure

Total Debt

$40M

Net Debt

-$947.6M

Denali Therapeutics Inc. currently has $40M in total debt. Net debt is -$947.6M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

DNLIQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.040.99-0.95Net Cash1.273.2%
2025-12-310.040.87-0.83Net Cash1.143.2%
2025-09-300.040.85-0.80Net Cash1.064.2%
2025-06-300.050.90-0.85Net Cash1.174.0%
2025-03-310.050.82-0.77Net Cash1.273.8%
2024-12-310.050.83-0.78Net Cash1.373.5%
2024-09-300.050.84-0.78Net Cash1.453.6%
2024-06-300.050.90-0.85Net Cash1.503.2%
2024-03-310.050.94-0.89Net Cash1.583.2%
2023-12-310.051.03-0.98Net Cash1.154.5%
2023-09-300.051.11-1.06Net Cash1.244.4%
2023-06-300.061.19-1.14Net Cash1.314.3%
2023-03-310.061.29-1.23Net Cash1.414.1%
2022-12-310.061.34-1.28Net Cash1.464.1%
2022-09-300.061.11-1.04Net Cash1.235.1%
2022-06-300.061.07-1.01Net Cash1.294.8%
2022-03-310.060.96-0.89Net Cash1.324.8%
2021-12-310.060.87-0.80Net Cash1.404.6%
2021-09-300.071.04-0.97Net Cash1.454.5%
2021-06-300.071.31-1.24Net Cash1.514.4%
2021-03-310.071.41-1.35Net Cash1.554.4%
2020-12-310.071.47-1.40Net Cash1.604.3%
2020-09-300.070.96-0.89Net Cash1.076.5%
2020-06-300.070.55-0.48Net Cash0.6511.0%
2020-03-310.070.59-0.52Net Cash0.7010.3%
2019-12-310.070.42-0.34Net Cash0.5513.1%
2019-09-300.070.48-0.41Net Cash0.6011.6%
2019-06-300.070.48-0.41Net Cash0.6411.1%
2019-03-310.070.49-0.41Net Cash0.6810.6%
2018-12-310.000.46-0.46Net Cash0.660.0%
2018-09-300.000.37-0.37Net Cash0.540.0%
2018-06-300.000.37-0.37Net Cash0.570.0%
2018-03-310.000.37-0.37Net Cash0.610.0%
2017-12-310.000.41-0.41Net Cash0.490.0%
2017-09-300.000.19-0.19Net Cash0.210.0%
2017-06-300.000.19-0.19Net Cash0.230.0%
2017-03-310.000.18-0.18Net Cash0.00
2016-12-310.000.18-0.18Net Cash0.270.0%